NEURO-musculoskeletal dz Flashcards
(235 cards)
What is the pathology of myasthenia gravis
Autoimmune dz
IgG antibodies destroy post-junctional nicotinic, ACh receptors at the NMJ
What is deficient in patients with myasthenia gravis
Nicotinic receptors
There is plenty of ACh
What is a key feature of myasthenia gravis
Skeletal muscle weakness that becomes WORSE LATER in the day or with exercise
Periods of rest allow skeletal muscle function recovery
Which organ plays a key role in myasthenia gravis
Thymus gland
What are 5 symptoms of myasthenia gravis
- Diplopia
- Ptosis
- Bulbar muscle weakness (dysphagia, dysarthria)
- Dyspnea on exertion
- Proximal muscle weakness
What are 5 situations that exacerbate myasthenia gravis symptoms
- Pregnancy
- Infection
- Electrolyte abnormalities
- Surgical and psychological stress
- Aminoglycoside abx
How does myasthenia gravis affect a neonate
Anti-AchR IgG antibodies cross the placenta and cause weakness in up to 20% of neonates for 2 - 4 weeks
Considerations for neonates of parturients with myasthenia gravis
Neonate may require airway mgmt
What is the first line medication used for myasthenia gravis
Anticholinesterases
-Pyridostigmine
How can the cause of acute weakness for a patient with myasthenia gravis who is taking pyridostigmine be determined
Give edrophonium 1 - 2 mg IV
- If weakness worsens, pt has cholinergic crisis
- I muscle strength improves, the patient has myasthenic crisis
A patient has increased weakness when edrophonium is given to determine the cause of myasthenia weakness while taking pyridostigmine. Why is weakness worsening and what should be given
Patient has anticholinergic crisis caused by increased ACh at the NMJ in the presence of an anticholinesterase
Patient should be given an anticholinergic medication
What medications are used for immunosuppression in myasthenia gravis
corticosteroids
cyclosporine
azathioprine
mycophenolate
Surgical procedure indicated for pts with myasthenia gravis
Thymectomy = reduces circulating anti-AchR IgG
Additional treatment for myasthenia gravis
Plasmapheresis can provide relief during myasthenic crisis before thymectomy
What test is used to distinguish between cholinergic crisis and myasthenic crisis
Tensilon test (edrophonium 1-2 mg IV)
How are patients with myasthenia gravis affected by nondepolarizing and depolarizing NMBD
Nondepolarizer = INCREASED sensitivity Depolarizers = DECREASED sensitivity (resistant)
Why do patients with myasthenia gravis have altered responses to NMB drugs
D/t fewer nicotinic receptors (type-m) at the NMJ
- resistant to succinylcholine
- increased sensitivity to nondepolarizers
How should the dose for nondepolarizing NMBD be adjusted in patients with myasthenia gravis
Potency is increased
Reduce dose by 1/2 or 1/3 and monitor response with nerve stimulator
How should the dose for succinylcholine be adjusted in patients with myasthenia gravis
Potency decreased
If RSI is required, increase dose to 1.5 - 2.0 mg/kg
How does pyridostigmine use in patients with myasthenia gravis affect succinylcholine metabolism
Pseudocholinesterase efficacy is impaired
Succs duration is prolonged
In myasthenia gravis pts, what is a primary postoperative concern
If NMB drugs was used, there’s a higher risk of residual neuromuscular blockade
What are postoperative patients with myasthenia gravis at increased risk for
Pulmonary aspiration d/t bulbar muscle weakness
What are 5 factors that increase the risk of postoperative mechanical ventilation in myasthenia gravis pts
- Dz duration >6 years
- Daily pyridostigmine >750 mg/day
- Vital capacity <2.9 L
- COPD
- Surgical procedure: median sternotomy > transcervical thymectomy
What is Eaton-Lambert syndrome
Disorder of NMJ resulting in skeletal muscle weakness